Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ring

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Pathology|July 1, 1990
Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytologyD S Leslie, W W Johnston, L Daly, et al.
Blood|June 1, 1986
Selective inhibition of the growth of human erythroid bursts by monoclonal antibodies against transferrin or the transferrin receptorK M Shannon, J W Larrick, S A Fulcher, et al.
International Journal of Cell Cloning|September 1, 1990
Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chainK M Shannon, D B Ring, L L Houston, et al.
Cancer Research|October 15, 1995
Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIIIL M Weiner, J I Clark, M Davey, et al.
Journal of Pediatric Psychology|May 13, 2009
Validity of social-cognitive measures for physical activity in middle-school girlsRod K Dishman, Derek P Hales, James F Sallis, et al.
Molecular Immunology|November 1, 1988
Targeted cytotoxic cells as a novel form of cancer immunotherapyD M Segal, M A Garrido, P Perez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1L M Weiner, M Holmes, A Richeson, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.
Cancer Research|June 1, 1989
Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancerD B Ring, J A Kassel, S T Hsieh-Ma, et al.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|July 1, 1990
Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytologyD S Leslie, W W Johnston, L Daly, et al.
Blood|June 1, 1986
Selective inhibition of the growth of human erythroid bursts by monoclonal antibodies against transferrin or the transferrin receptorK M Shannon, J W Larrick, S A Fulcher, et al.
International Journal of Cell Cloning|September 1, 1990
Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chainK M Shannon, D B Ring, L L Houston, et al.
Cancer Research|October 15, 1995
Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIIIL M Weiner, J I Clark, M Davey, et al.
Journal of Pediatric Psychology|May 13, 2009
Validity of social-cognitive measures for physical activity in middle-school girlsRod K Dishman, Derek P Hales, James F Sallis, et al.
Molecular Immunology|November 1, 1988
Targeted cytotoxic cells as a novel form of cancer immunotherapyD M Segal, M A Garrido, P Perez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1L M Weiner, M Holmes, A Richeson, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.
Cancer Research|June 1, 1989
Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancerD B Ring, J A Kassel, S T Hsieh-Ma, et al.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Pageof 6